van Puijenbroek EP - Search Results

1

Monitoring adverse events of vaccines against Mexican flu.

van Puijenbroek EP, van Grootheest AC. van Puijenbroek EP, et al. Among authors: van grootheest ac. Int J Risk Saf Med. 2011;23(2):81-7. doi: 10.3233/JRS-2011-0525. Int J Risk Saf Med. 2011. PMID: 21673415

2

[Clinical thinking and decision-making in practice. A patient with persistent fever].

Diemont WL, van Puijenbroek EP, van Grootheest AC. Diemont WL, et al. Among authors: van puijenbroek ep, van grootheest ac. Ned Tijdschr Geneeskd. 2000 Sep 16;144(38):1853-5. Ned Tijdschr Geneeskd. 2000. PMID: 11020842 Dutch. No abstract available.

3

A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions.

van Puijenbroek EP, Bate A, Leufkens HG, Lindquist M, Orre R, Egberts AC. van Puijenbroek EP, et al. Pharmacoepidemiol Drug Saf. 2002 Jan-Feb;11(1):3-10. doi: 10.1002/pds.668. Pharmacoepidemiol Drug Saf. 2002. PMID: 11998548

4

Contribution of pharmacists to the reporting of adverse drug reactions.

van Grootheest AC, van Puijenbroek EP, de Jong-van den Berg LT. van Grootheest AC, et al. Among authors: van puijenbroek ep. Pharmacoepidemiol Drug Saf. 2002 Apr-May;11(3):205-10. doi: 10.1002/pds.702. Pharmacoepidemiol Drug Saf. 2002. PMID: 12051119

5

Application of quantitative signal detection in the Dutch spontaneous reporting system for adverse drug reactions.

van Puijenbroek E, Diemont W, van Grootheest K. van Puijenbroek E, et al. Drug Saf. 2003;26(5):293-301. doi: 10.2165/00002018-200326050-00001. Drug Saf. 2003. PMID: 12650632

6

The Weber-curve pitfall: effects of a forced introduction on reporting rates and reported adverse reaction profiles.

de Graaf L, Fabius MA, Diemont WL, van Puijenbroek EP. de Graaf L, et al. Among authors: van puijenbroek ep. Pharm World Sci. 2003 Dec;25(6):260-3. doi: 10.1023/b:phar.0000006518.22231.ea. Pharm World Sci. 2003. PMID: 14689813

7

[Notifications to the Netherlands Pharmacovigilance Foundation Lareb of the expulsion of a vaginal contraceptive ring (NuvaRing) and of pregnancy during the use of it].

Passier JL, van Puijenbroek EP, van Grootheest AC. Passier JL, et al. Among authors: van puijenbroek ep, van grootheest ac. Ned Tijdschr Geneeskd. 2004 Oct 9;148(41):2033-5. Ned Tijdschr Geneeskd. 2004. PMID: 15554002 Dutch.

8

[Direct reporting of side effects by the patient: favourable experience in the first year].

van Grootheest AC, Passier JL, van Puijenbroek EP. van Grootheest AC, et al. Among authors: van puijenbroek ep. Ned Tijdschr Geneeskd. 2005 Mar 5;149(10):529-33. Ned Tijdschr Geneeskd. 2005. PMID: 15782689 Dutch.

9

Post Launch Monitoring of food products: what can be learned from pharmacovigilance.

van Puijenbroek EP, Hepburn PA, Herd TM, van Grootheest AC. van Puijenbroek EP, et al. Among authors: van grootheest ac. Regul Toxicol Pharmacol. 2007 Mar;47(2):213-20. doi: 10.1016/j.yrtph.2006.10.007. Epub 2007 Jan 3. Regul Toxicol Pharmacol. 2007. PMID: 17204356

10

Spontaneous ADR reports as a trigger for pharmacogenetic research: a prospective observational study in the Netherlands.

van Puijenbroek E, Conemans J, van Grootheest K. van Puijenbroek E, et al. Drug Saf. 2009;32(3):255-64. doi: 10.2165/00002018-200932030-00008. Drug Saf. 2009. PMID: 19338383

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

222 results

Search Page

Filters